Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Armand

Showing results (61-70 of 273) with videos related to

Pageof 28
Sort By:
American Journal of Surgery|March 14, 2019
Emergency general surgery procedures in hematopoietic stem cell transplant recipientsSharven Taghavi, Manuel Castillo-Angeles, Tarsicio Uribe-Leitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host DiseaseNathaniel Treister, Shuli Li, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Leukemia|August 22, 2020
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patientsMatthew S Davids, David C Fisher, Svitlana Tyekucheva, et al.
Leukemia & Lymphoma|May 11, 2019
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemiaJacob D Soumerai, Matthew S Davids, Lillian Werner, et al.
Hemasphere|August 11, 2025
Working towards harmonization of clinical trial reporting in Hodgkin lymphomaCarsten Kobe, Philippe Armand, Sven Borchmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin FailurePhilippe Armand, Margaret A Shipp, Vincent Ribrag, et al.
Leukemia & Lymphoma|November 25, 2020
A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assayMatthew L Chase, Reid Merryman, David C Fisher, et al.
Pageof 28

Showing results (61-70 of 273) with videos related to

Sort By:
Pageof 28
American Journal of Surgery|March 14, 2019
Emergency general surgery procedures in hematopoietic stem cell transplant recipientsSharven Taghavi, Manuel Castillo-Angeles, Tarsicio Uribe-Leitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host DiseaseNathaniel Treister, Shuli Li, Haesook Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantationBradley W Blaser, Haesook T Kim, Edwin P Alyea, et al.
Leukemia|August 22, 2020
A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patientsMatthew S Davids, David C Fisher, Svitlana Tyekucheva, et al.
Leukemia & Lymphoma|May 11, 2019
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemiaJacob D Soumerai, Matthew S Davids, Lillian Werner, et al.
Hemasphere|August 11, 2025
Working towards harmonization of clinical trial reporting in Hodgkin lymphomaCarsten Kobe, Philippe Armand, Sven Borchmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2015
Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcomeHaesook T Kim, Philippe Armand, David Frederick, et al.
Haematologica|June 20, 2015
Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantationNatasha Kekre, Haesook T Kim, Gita Thanarajasingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin FailurePhilippe Armand, Margaret A Shipp, Vincent Ribrag, et al.
Leukemia & Lymphoma|November 25, 2020
A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assayMatthew L Chase, Reid Merryman, David C Fisher, et al.
Pageof 28